CHARACTERIZATION OF A YAC CONTAINING PART OR ALL OF THE NORRIE DISEASE LOCUS

被引:11
作者
CHEN, ZY
SIMS, KB
COLEMAN, M
DONNAI, D
MONACO, A
BREAKEFIELD, XO
DAVIES, KE
CRAIG, IW
机构
[1] DEPT BIOCHEM, GENET LAB, OXFORD OX1 3QU, England
[2] MASSACHUSETTS GEN HOSP E, CTR NEUROSCI, MOLEC NEUROGENET LAB, BOSTON, MA 02129 USA
[3] JOHN RADCLIFFE HOSP, INST MOLEC MED, OXFORD OX3 9DU, England
[4] ST MARYS HOSP, MANCHESTER M13 0JH, LANCS, England
关键词
D O I
10.1093/hmg/1.3.161
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been shown from pulsed-field gel electrophoresis (PFGE) that the monoamine oxidase genes A and B (MAOA & MAOB) and DXS7 loci are physically very close. We have therefore extended studies on their relationship through the characterisation of a 650 kb YAC isolated using L1.28 (recognising the DXS7 locus) as a probe. Restriction mapping of the YAC indicates that it contains both MAOA and MAOB genes in addition to the DXS7 locus. The map derived from the YL1.28-YAC is compatible both with the map from an independently derived YAC carrying MAOA and B genes and with the long range genomic map for the region. A series of subclones prepared from a 'phage library (lambda DASH II) of the YAC have been characterised and have been empLoyed to determine the end point of the deletion of a Norrie disease (NDP) patient who has been shown to lack both DXS7 and MAO coding sequences. The pattern of retention of subclones in the deletion patient place the end point of the deletion within 30-130 kb of the proximal end of the YAC. By combining the data with established recombination analysis, we provide evidence that all or part of the NDP lies in the interval of approximately 250kb within the YAC.
引用
收藏
页码:161 / 164
页数:4
相关论文
共 21 条
[1]  
ANAND R, 1990, GEL ELECTROPHORESIS, P101
[2]  
CHEN ZY, 1992, IN PRESS GENOMICS
[3]   CLINICAL, BIOCHEMICAL, AND NEUROPSYCHIATRIC EVALUATION OF A PATIENT WITH A CONTIGUOUS GENE SYNDROME DUE TO A MICRODELETION XP11.3 INCLUDING THE NORRIE DISEASE LOCUS AND MONOAMINE-OXIDASE (MAOA AND MAOB) GENES [J].
COLLINS, FA ;
MURPHY, DL ;
REISS, AL ;
SIMS, KB ;
LEWIS, JG ;
FREUND, L ;
KAROUM, F ;
ZHU, DP ;
MAUMENEE, IH ;
ANTONARAKIS, SE .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1992, 42 (01) :127-134
[4]   REPORT OF THE COMMITTEE-ON-THE-GENETIC-CONSTITUTION-OF-THE-X-CHROMOSOME [J].
DAVIES, KE ;
MANDEL, JL ;
MONACO, AP ;
NUSSBAUM, RL ;
WILLARD, HF .
CYTOGENETICS AND CELL GENETICS, 1991, 58 (1-2) :853-966
[5]  
DELACHAPELLE A, 1985, CLIN GENET, V28, P317
[6]   PHYSICAL FINE-MAPPING OF A DELETION SPANNING THE NORRIE-GENE [J].
DIERGAARDE, PJ ;
WIERINGA, B ;
BLEEKERWAGEMAKERS, EM ;
SIMS, KB ;
BREAKEFIELD, XO ;
ROPERS, HH .
HUMAN GENETICS, 1989, 84 (01) :22-26
[7]  
DONNAI D, 1988, J MED GENET, V43, P575
[8]   SUBMICROSCOPIC INTERSTITIAL DELETION OF THE X-CHROMOSOME EXPLAINS A COMPLEX GENETIC SYNDROME DOMINATED BY NORRIE DISEASE [J].
GAL, A ;
WIERINGA, B ;
SMEETS, DFCM ;
BLEEKERWAGEMAKERS, L ;
ROPERS, HH .
CYTOGENETICS AND CELL GENETICS, 1986, 42 (04) :219-224
[9]   STRUCTURAL FEATURES OF HUMAN MONOAMINE OXIDASE-A ELUCIDATED FROM CDNA AND PEPTIDE SEQUENCES [J].
HSU, YPP ;
WEYLER, W ;
SHIUAN, C ;
SIMS, KB ;
RINEHART, WB ;
UTTERBACK, MC ;
POWELL, JF ;
BREAKEFIELD, XO .
JOURNAL OF NEUROCHEMISTRY, 1988, 51 (04) :1321-1324
[10]   1ST DEMONSTRATION OF RECOMBINATION BETWEEN THE GENE FOR NORRIE DISEASE AND PROBE L1.28 [J].
KATAYAMA, S ;
WOHLFERD, M ;
GOLBUS, MS .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1988, 30 (04) :967-970